<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html>
<head>
<title>
Int'l Rehabilitative Sciences, Inc. v. Sebelius, 688 F.3d 994 (9th Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>

<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"bam.nr-data.net","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkDA1YSFkYGRx9dDlUTCANZEkxQDFdFVARYEkoVXwkU","queueTime":0,"applicationTime":1642,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-411.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function(t,n,e){function r(e){if(!n[e]){var o=n[e]={exports:{}};t[e][0].call(o.exports,function(n){var o=t[e][1][n];return r(o?o:n)},o,o.exports)}return n[e].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<e.length;o++)r(e[o]);return r}({D5DuLP:[function(t,n){function e(t,n){var e=r[t];return e?e.apply(this,n):(o[t]||(o[t]=[]),void o[t].push(n))}var r={},o={};n.exports=e,e.queues=o,e.handlers=r},{}],handle:[function(t,n){n.exports=t("D5DuLP")},{}],G9z0Bl:[function(t,n){function e(){var t=l.info=NREUM.info;if(t&&t.agent&&t.licenseKey&&t.applicationID&&p&&p.body){l.proto="https"===f.split(":")[0]||t.sslForHttp?"https://":"http://",i("mark",["onload",a()]);var n=p.createElement("script");n.src=l.proto+t.agent,p.body.appendChild(n)}}function r(){"complete"===p.readyState&&o()}function o(){i("mark",["domContent",a()])}function a(){return(new Date).getTime()}var i=t("handle"),u=window,p=u.document,s="addEventListener",c="attachEvent",f=(""+location).split("?")[0],l=n.exports={offset:a(),origin:f,features:[]};p[s]?(p[s]("DOMContentLoaded",o,!1),u[s]("load",e,!1)):(p[c]("onreadystatechange",r),u[c]("onload",e)),i("mark",["firstbyte",a()])},{handle:"D5DuLP"}],loader:[function(t,n){n.exports=t("G9z0Bl")},{}]},{},["G9z0Bl"]);</script>
<meta content="authenticity_token" name="csrf-param" />
<meta content="LpSXuBb3zp4DxNnwkq54A2leqj4MsxHanJdvSqU4rnE=" name="csrf-token" />
<script src="/assets/bundles/framework-eae4a8a53596620ce1e5ae01ad595fc6.js" type="text/javascript"></script>
<script src="/assets/notifications/manifest-ba826cb4e872343ba4a579d13cec9962.js" type="text/javascript"></script>

<script src="/assets/daterange-093adab9c1f994f32a18b6f919d7c263.js" type="text/javascript"></script>
<script src="/assets/document/document-0488af9ce3da6a72d934b28be3286ad7.js" type="text/javascript"></script>
<script src="/assets/document/document_viewer-13ae7b804b4ae82422c7307728bb9e17.js" type="text/javascript"></script>
<script src="/assets/document/bciteutils-5aa143439020b5924eb59ac7e16e3fee.js" type="text/javascript"></script>
<script src="/assets/jquery/jquery.query-54e7b318cc4a8051b453d397154fa43d.js" type="text/javascript"></script>
<script src="/assets/browser/browser-e31363c57f0e7ed6c11f9b845eaa7644.js" type="text/javascript"></script>
<script src="/assets/document/image_viewer-27e887de136b30a2709ca4be807d7803.js" type="text/javascript"></script>
<script src="/assets/jquery/jquery.selection-8a59c9131d3ebeea8be09ad279ed367b.js" type="text/javascript"></script>
<script src="/assets/jquery/jquery.bb-copywithcitation-38a73cc6f2e2beaa0e81742ef480d4a4.js" type="text/javascript"></script>
<script src="/assets/document/copy_with_cite-2a4e1e7145c923de1118b82364051ccb.js" type="text/javascript"></script>
<script src="/assets/document/notepad-392dd24bb3f85e83ea74fcc917c8c688.js" type="text/javascript"></script>

<link href="/assets/yui2/yui2_combo.min-b1475227757d98fb06cb9f954d4a5acd.css" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/assets/bundles/framework-99b0571f2eeb544e53c2c448a0023f49.css" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/assets/ie-252d25240f309444c4734964fcbae4ba.css" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/assets/search/search_results-9057d2c8a17d32835dc4181fc46cf73a.css" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/assets/document-9a2653b3102de1ff1774c140c1d9b9b1.css" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/assets/document_viewer-88de869a1e74ece2dfc54758a0e8e7a4.css" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/assets/search/tree_view-59c45d34d0ad4cf8445991bd68f2ba32.css" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/assets/browser/browser_enhanced-c639b16d3fef93141c12649cfc7f067e.css" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:#FFE303;
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/assets/yui_calendar-9826afb24cd0268dc17880dcdf153203.css" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/assets/docviewer_overrides-a048a6f4b399e690761e1def05eea8be.css" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/assets/print-99fe3e9fd40a2376a469854cc033f95b.css" media="print" rel="stylesheet" type="text/css" />
<link href='/assets/favicon-34d63cbc312fbdca70f1a13f87458560.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container' id='page_wrapper'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/assets/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class="logout "><a href="/log_out.htm" class="topTab" id="logoutButton" onclick="generateExplicitLogoutEvent();"><div>Logout</div></a></li>
<li class='help'>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="topTab" target="_blank">Help</a>
</li>
<li class='' id='user'>
<a href="/settings"><div class='topTab'>Susan Yeh</div>
</a></li>
<li class='withNotifications ' id='client_matter'>
<div class='clientMatterDropDown topTab'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<div class='noneSelected' style=''>
&nbsp;(None Selected)
</div>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none;'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Client Matter'>
Remove Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications ' id='alerts'>
<a href="/alerts/inbox"><div class='topTab' id='unreadAlertsCount'>
<div>Saved Searches & Alerts</div>
</div>
</a></li>
<li class='withNotifications ' id='downloads'>
<a href="/download/download_center"><div class='topTab' id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a></li>
<li class='' id='research_trail'>
<a href="/research_trail"><div class='topTab'>Research Trail</div>
</a></li>
<li class='' id='workspaces'>
<a href="/workspaces"><div class='topTab'>Workspaces</div>
</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="LpSXuBb3zp4DxNnwkq54A2leqj4MsxHanJdvSqU4rnE=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>
<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='navLink clearfix' href='/legal_search'>
All Legal Content
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/company_search'>
Company Screener
</a>
</li>
<li>
<a class='navLink clearfix' href='/opinion_search'>
Court Opinions
</a>
</li>
<li>
<a class='navLink clearfix' href='/dealmaker_document_search'>
DealMaker Documents
</a>
</li>
<li>
<a class='navLink clearfix' href='/dockets'>
Dockets
</a>
</li>
<li>
<a class='navLink clearfix' href='/dnds_search'>
Domain Name Decisions
</a>
</li>
<li>
<a class='navLink clearfix' href='/edgar_search'>
EDGAR
</a>
</li>
<li>
<a class='navLink clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
EDGAR Comment Threads
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='navLink clearfix' href='/leg_search'>
Legislative
</a>
</li>
<li>
<a class='navLink clearfix' href='/news/advanced_search'>
News
</a>
</li>
<li>
<a class='navLink clearfix' href='/patent_search'>
Patents
</a>
</li>
<li>
<a class='navLink clearfix' href='/people_search'>
People
</a>
</li>
<li>
<a class='navLink clearfix' href='/reg_search'>
Regulatory
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/no_action_search'>
SEC No-Action Letters
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='navLink clearfix' href='/law_reports'>
BNA Law Reports
</a>
</li>
<li>
<a class='navLink clearfix' href='/nav_content_menu/105.456024'>
BNA Manuals
</a>
</li>
<li>
<a class='navLink clearfix' href='/nav_content_menu/105.456026'>
BNA Portfolios
</a>
</li>
<li>
<a class='navLink clearfix' href='/nav_content_menu/105.102923'>
Books & Treatises
</a>
</li>
<li>
<a class='navLink clearfix' href='/nav_content_menu/105.293113'>
Federal Law
</a>
</li>
<li>
<a class='navLink clearfix' href='/map_nav/laws_regs'>
State Law
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/antitrust'>
Antitrust
</a>
</li>
<li>
<a class='navLink clearfix' href='/banking_finance'>
Banking & Finance
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/bankruptcy'>
Bankruptcy
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/corporate_ma'>
Corporate/M&A
</a>
</li>
<li>
<a class='navLink clearfix' href='/employee_benefits'>
Employee Benefits
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/health'>
Health
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/ip_law'>
Intellectual Property
</a>
</li>
<li>
<a class='navLink clearfix' href='/labor_employment'>
Labor & Employment
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='navLink clearfix' href='/securities'>
Securities
</a>
</li>
<li>
<a class='navLink clearfix' href='/tax'>
Tax
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/opinion_search'>
Search Court Opinions
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/nav_menu/X7TO28O'>
BNA Outlines & Headnotes
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='navLink clearfix' href='/nav_content_menu/105.103000'>
Federal Rules
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/general'>
Litigation Resources
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/dockets'>
Search Dockets
</a>
</li>
<li>
<a class='navLink clearfix' href='/dockets/breaking'>
Breaking Complaints
</a>
</li>
<li>
<a class='navLink clearfix' href='/dockets/analytics'>
Docket Analytics
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='navLink clearfix' href='/dockets/coverage'>
Docket Coverage
</a>
</li>
<li>
<a class='navLink clearfix' href='/dockets/requests'>
Docket Requests
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/dockets/tracking'>
Docket Tracking
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/edgar_search'>
EDGAR
</a>
</li>
<li>
<a class='navLink clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
EDGAR Comment Threads
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/example_and_saved_searches'>
Example Searches
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='navLink clearfix' href='/dealmaker_document_search'>
DealMaker Documents
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/dealmaker_clause_search'>
DealMaker Clauses
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/deal_maker/current_awareness'>
Current Awareness
</a>
</li>
<li>
<a class='navLink clearfix' href='/nav_menu/X7TS80O'>
Drafting Guides & Overviews
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='navLink clearfix' href='/nav_menu/X7TVS0O'>
Transactional Legal Treatises
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/deal_maker/resources'>
Transactional Resources
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/leg_search'>
Search Legislative
</a>
</li>
<li>
<a class='navLink clearfix' href='/leg_search/congressional_bill_search'>
Search Congressional Bills
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/nav_browser/105.24221'>
U.S. Code
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='navLink clearfix' href='/map_nav/laws_regs'>
State Legislative Materials
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/leg_news_analysis'>
Legislative Resources
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/reg_search'>
Search Regulatory
</a>
</li>
<li>
<a class='navLink clearfix' href='/reg_search/federal_register_search'>
Search Federal Register
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/nav_browser/105.24230'>
Code of Federal Regulations
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='navLink clearfix' href='/map_nav/laws_regs'>
State Regulatory Materials
</a>
</li>
<li>
<a class='navLink clearfix' href='/reg_updates'>
Monitor Regulators
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/reg_news_analysis'>
Regulatory Resources
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/law_reports'>
BNA Law Reports
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/nav_content_menu/105.456024'>
BNA Manuals
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='navLink clearfix' href='/nav_content_menu/105.456026'>
BNA Portfolios
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/nav_content_menu/105.102923'>
Books & Treatises
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/news/advanced_search'>
Search News
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/news'>
Legal News
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='navLink clearfix' href='/news/topic'>
News by Topic
</a>
</li>
<li>
<a class='navLink clearfix' href='/news/top_news'>
TOP News
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/business_development'>
Business Development Center
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/edgar_search'>
Search EDGAR
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='navLink clearfix' href='/company'>
Company Watchlist
</a>
</li>
<li class='last'>
<a class='navLink clearfix' href='/company_search'>
Company Screener
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='navLink clearfix' href='/report_writer'>
Company Report Writer
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='navLink clearfix' href='/market'>
Market News
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
</div>
<div class='breadcrumbSpacer printHide'></div>

<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation positive" title="Positive"></div>
<div class='title left' title="Int'l Rehabilitative Sciences, Inc. v. Sebelius, 688 F.3d 994 (9th Cir. 2012), Court Opinion">
Int'l Rehabilitative Sciences, Inc. v. Sebelius, 688 F.3d 994 (9th Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>Int'l Rehabilitative Sciences, Inc. v. Sebelius, 688 F.3d 994 (9th Cir. 2012), Court Opinion</div>
<div class='docId'>X1I1GKO003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>Int'l Rehabilitative Sciences, Inc. v. Sebelius</div>
<div class='displayCitation'>2012 BL 190064</div>
<div class='displayCitation'>688 F.3d 994</div>
<div class='displayCitation'>bna a0d3x1c4h4</div>
<div class='displayCitation'>wkf9case:26239308</div>
</div>

<div class='search_outline_node_popup' style='display:none'>

<form accept-charset="UTF-8" action="/p//class_outline_search/X1I1GKO003" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="LpSXuBb3zp4DxNnwkq54A2leqj4MsxHanJdvSqU4rnE=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text submitOnEnter" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/assets/transparency-e1f31bbf186088cccb5027f3bdc72bc9.png" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  $('#page_content').addClass("invisible");
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1I1GKO003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="Int&#x27;l Rehabilitative Sciences, Inc. v. Sebelius, 688 F.3d 994 (9th Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="Int&#x27;l Rehabilitative Sciences, Inc. v. Sebelius" />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="LpSXuBb3zp4DxNnwkq54A2leqj4MsxHanJdvSqU4rnE=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/document/X1I1GKO003" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1I1GKO003" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1I1GKO003" /><input id="title" name="title" type="hidden" value="Int&#x27;l Rehabilitative Sciences, Inc. v. Sebelius, 688 F.3d 994 (9th Cir. 2012), Court Opinion" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="POSITIVE" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1I1GKO003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="false" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm(&#x27;download&#x27;,&#x27;downloadPopupLinkForm&#x27;); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm(&#x27;email&#x27;,&#x27;downloadPopupLinkForm&#x27;); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm(&#x27;add_to_workspace&#x27;,&#x27;?resource_path=%2Fdocument%2FX%31I%31GKO%30%30%33&amp;document_type=OPINIONS&#x27;, null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='docTabs'>
<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/bcite/X1I1GKO003/history?bc=W1siRG9jdW1lbnQiLCIvZG9jdW1lbnQvWDFJMUdLTzAwMyJdXQ==" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/bcite/X1I1GKO003/analysis?bc=W1siRG9jdW1lbnQiLCIvZG9jdW1lbnQvWDFJMUdLTzAwMyJdXQ==" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/bcite/X1I1GKO003/toa?bc=W1siRG9jdW1lbnQiLCIvZG9jdW1lbnQvWDFJMUdLTzAwMyJdXQ==" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/related_content/X1I1GKO003?bc=W1siRG9jdW1lbnQiLCIvZG9jdW1lbnQvWDFJMUdLTzAwMyJdXQ==" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'>
</span>
</a>
</div>
</div>

</div>

</div>
<!-- document -->
<script type='text/javascript'>
  var fluid_layout=false;
</script>
<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal  ' id='doc_holder'>
<div class='documentContent ' id='content_document'>
<div id='chunk_content'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1719619289091";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "#FFE303";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">688 F.3d 994</div>
<div class="cite" data-cite-type="DocketNumber">11-35254</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 190064</div>
</div>
</div>
<div align="left" class="tableofcontents">
<div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Ninth Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
INTERNATIONAL REHABILITATIVE SCIENCES INC., a Washington corporation, DBA RS
Medical, Plaintiff-Appellee, v. Kathleen SEBELIUS, in her official capacity
as Secretary, United States Department of Health and Human Services; United
States Department of Health and Human Services, Defendants-Appellants.
</center></p>
<hr align="center" width="65%">
<p><center>
No. 11-35254.
</center></p>

<p><center>
Argued and Submitted June 7, 2012.
</center></p>

<p><center>
Filed July 30, 2012.
<span CLASS="page_no" data-cite="688 f 3d 996" data-cite-type="PrimaryFederalReporter" data-cite-pageno="996" data-primary-citation="688 F.3d 994">[*996]</span> </center></p>

<div id="para2" printdualcolumn="true"><p>

Debra M. Parrish (argued), Parrish Law Offices, Pittsburgh, PA, and Renee M.
Howard and Sanford E. Pitler, Bennett Bigelow &amp; Leedom, P.S., Seattle, WA,
for the plaintiff-appellee.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Irene M. Solet (argued), Tony West, Jenny A. Durkan, Kerry Keefe, and
Michael S. Raab, United States Department of Justice, Washington, D.C. and
William B. Schultz, Pamela Parker, Janice L. Hoffman, Mark D. Polston, Janet
Freeman, Brett Bierer, and Gerard Keating, United States Department of
Health and Human Services, Washington, D.C. for the defendants-appellants.
</p></div>

<div id="para2" printdualcolumn="true"><p>
Appeal from the United States District Court for the Western District of
Washington, Ronald B. Leighton, District Judge, Presiding. D.C. No.
3:08-cv-05442-RBL.

[EDITORS' NOTE: THIS PAGE CONTAINED HEADNOTES AND HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
</p></div>

<div id="para2" printdualcolumn="true"><p>
Before: BARRY G. SILVERMAN and MARY H. MURGUIA, Circuit Judges, and LESLIE
E. KOBAYASHI, District Judge.<a HREF="#fn*00" name="fnref_fn*00">[fn*]</a>
</p></div>
<div id="para2" printdualcolumn="true"><p>
<span class="fr"><a HREF="#fnref_fn*00" name="fn*00">[fn*]</a></span> The Honorable Leslie E. Kobayashi, United States District Judge for
the District of Hawaii, sitting by designation.
</p></div>
<div id="contentOpinion" printdualcolumn="true">
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>OPINION</b>
</p></div>
</div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  SILVERMAN, Circuit Judge:
</p></div>

<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Department of Health and Human Services, the agency that administers
Medicare, denied Medicare coverage for the BIO-1000, a piece of durable
medical equipment used to treat osteoarthritis of the knee. In four
decisions, the Medicare Appeals Council, which is the highest level of
agency adjudication, ruled that the BIO-1000 had not been shown to be
"reasonable and necessary" for the treatment at issue. The supplier of the
device challenges those decisions as arbitrary, capricious, and not
supported by substantial evidence.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Today we join the Fourth Circuit in holding that the Medicare Appeals
Council's coverage denials for the BIO-1000 were not arbitrary, capricious,
or unsupported by substantial evidence. <i>See Almy v. Sebelius</i>, <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">679 F.3d 297</a>,
<a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">305</a> (4th Cir.2012).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We hold that, although various ALJs in other cases had granted coverage
for the BIO-1000, those cases were at low levels of the agency adjudication
process and thus were not binding on the Medicare Appeals Council. The
Medicare Appeals Council adequately explained its reasons for denying
coverage here.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Furthermore, the coverage denials were supported by substantial evidence.
After reviewing the scientific studies submitted by the BIO-1000's supplier,
the Medicare Appeals Council reasonably concluded that those studies failed
to show the device was more effective at alleviating knee pain (the device's
primary asserted purpose) than a TENS device costing 80% less. And the
Medicare Appeals Council reasonably concluded that the studies failed to
show that the device was effective at regenerating cartilage (its secondary
asserted purpose) in humans.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We reverse the district court's grant of summary judgment for the
BIO-1000's supplier and remand <span CLASS="page_no" data-cite="2012 bl 190064 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[**2]</span> the case to the district court to determine
in the first instance whether the supplier of the device is entitled to the
benefit of any of Medicare's "limited liability" provisions.
<span CLASS="page_no" data-cite="688 f 3d 997" data-cite-type="PrimaryFederalReporter" data-cite-pageno="997" data-primary-citation="688 F.3d 994">[*997]</span> </p></div>

<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b><i>THE MEDICARE STATUTORY AND ADMINISTRATIVE REGIME</i></b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Medicare is the federal health insurance program for the elderly and
disabled. Part B &mdash; the part of the Medicare program at issue here &mdash; is
voluntary supplemental medical insurance covering doctors' services,
outpatient care, and durable medical equipment. <a href="/document/XEJAJE003?jcsearch=42%20usc%201395j&amp;summary=yes#jcite">42 U.S.C. &sect; 1395j</a>,
<a href="/document/XEJAJG003?jcsearch=42%20U.S.C.%20%201395k(a)(2)&amp;summary=yes#jcite">1395k</a>(a)(2), <a href="/document/XEJAJK003?jcsearch=42%20U.S.C.%20%201395m&amp;summary=yes#jcite">1395m</a>. It operates much like private medical insurance:
Medicare beneficiaries receive medical treatment and the providers submit
claims for government reimbursement. <a href="/document/XEJAJM003?jcsearch=42%20usc%201395n&amp;summary=yes#jcite">42 U.S.C. &sect; 1395n</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The government controls Medicare costs, among other ways, by denying
coverage claims for items or services that are not "reasonable and
necessary" for treatment. <a href="/document/XEJALA003?jcsearch=42%20U.S.C.%20%201395y(a)(1)(A)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395y</a>(a)(1)(A). A device is not
"reasonable and necessary" &mdash; and thus is not eligible for Medicare coverage
&mdash; if it is:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      &bull; Not "safe" and "effective" &mdash; that is, if the device has not
    "been proven safe and effective based on authoritative evidence" or
    is not "generally accepted in the medical community as safe and
    effective for the condition for which it is used";
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      &bull; "[E]xperimental" &mdash; that is, "investigational";
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      &bull; Not "[a]ppropriate" for the individual beneficiary's needs; or
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      &bull; "[S]ubstantially more costly than a medically appropriate and
    realistically feasible alternative pattern of care."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<a href="/document/1?citation=54%20federal%20register%204302&amp;summary=yes#jcite">54 Fed.Reg. 4302</a>, 4303-04 (Jan. 30, 1989); <a href="/document/1?citation=60%20federal%20register%2048417&amp;summary=yes#jcite">60 Fed.Reg. 48417</a>, 48418 (Sept.
19, 1995); Centers for Medicare &amp; Medicaid Servs., Dep't of Health &amp; Human
Servs., <i>Medicare Benefit Policy Manual</i>, ch. 15, <cite>&sect; 110.1[C][2]</cite>, available at
&lt;http://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads//bp102c15.pdf&gt;.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The burden is on the claimant to show that the device is reasonable and
necessary. <i>See, e.g., Almy v. Sebelius</i>, <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">679 F.3d 297</a>, <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">305</a> (4th Cir.2012);
<i>Friedman v. Sec'y of Dep't of Health &amp; Human Servs.</i>, <a href="/document/XAFI1L?jcsearch=819%20f%202d%2042&amp;summary=yes#jcite">819 F.2d 42</a>, <a href="/document/XAFI1L?jcsearch=819%20f%202d%2042&amp;summary=yes#jcite">45</a> (2d
Cir.1987).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Medicare contracts with private insurance carriers to determine coverage
claims in the first instance. <a href="/document/XEJAK6003?jcsearch=42%20U.S.C.%20%201395u(a)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395u</a>(a); 42 C.F.R. &sect; 405.920. If
a contractor denies a claim, the supplier may have another contractor
redetermine the claim. 42 C.F.R. &sect; 405.940; <a href="/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff%20(a)(3)(A)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395ff</a>(a)(3)(A<a href="/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff%20(a)(3)(B)&amp;summary=yes#jcite">)-(B).</a>
If the supplier is dissatisfied with the redetermination, it may have a
qualified independent contractor reconsider the claim. 42 C.F.R. &sect; 405.960;
<a href="/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(b)(1)(A)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395ff</a>(b)(D(A), <a href="/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(c)(3)(B)&amp;summary=yes#jcite">(c)(3)(B).</a> If the supplier is dissatisfied with
the qualified independent contractor's reconsideration decision, it may have
its claim heard before an ALJ. 42 C.F.R. &sect; 405.1000 &amp; 405.1002;
<a href="/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(d)(1)(A)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395ff</a>(d)(1)(A). If the supplier is dissatisfied with the ALJ's
decision, it may appeal the decision to the Medicare Appeals Council, a
division of the Department of Health and Human Services.
42 C.F.R. &sect; 405.1100; <a href="/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(d)(2)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395ff</a>(d)(2). Alternatively, the Medicare
Appeals Council may on its own motion review the ALJ's decision.
42 C.F.R. &sect; 405.1110. Each of these administrative appeals applies de novo
review. 42 C.F.R. &sect; 405.1000(d); 42 C.F.R. &sect; 405.1100(c). The Medicare
Appeals Council's decision is the agency's final decision.
42 C.F.R. &sect; 405.1130.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  If the supplier is dissatisfied with the Medicare Appeals Council's
decision, it may challenge that decision in federal court.
<a href="/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(b)(1)(A)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395ff</a>(b)(1)(A).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Even if a coverage claim is denied on the ground that the items or
services were not "reasonable or necessary," Medicare will nevertheless pay
for the items or services if the supplier and the beneficiary "did not know,
and could <span CLASS="page_no" data-cite="2012 bl 190064 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[**3]</span> not reasonably have been expected to know, that payment
<span CLASS="page_no" data-cite="688 f 3d 998" data-cite-type="PrimaryFederalReporter" data-cite-pageno="998" data-primary-citation="688 F.3d 994">[*998]</span> 
would not be made for such items or services." <a href="/document/XEJAMC003?jcsearch=42%20U.S.C.%20%201395pp(a)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395pp</a>(a).
However, once Medicare indemnifies a supplier for an unforeseen claim denial
under this "limited liability" provision, the supplier is deemed to know
that Medicare will not pay any future claims for the same or similar items
or services. <a href="/document/XEJAMC003?jcsearch=42%20U.S.C.%20%201395pp(b)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395pp</a>(b).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A supplier can shift the risk of coverage denial to the Medicare
beneficiary by notifying the beneficiary in writing that Medicare will
likely deny coverage. 42 C.F.R. &sect; 411.404. These advance beneficiary notices
"allow beneficiaries to make an informed consumer decision about receiving
items or services for which they may have to pay out-of-pocket." <i>Medicare</i>
<i>Benefit Policy Manual</i>, ch. 15, &sect; 110.1[C].
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  However, for the supplier to shift liability to the beneficiary, the
supplier's notice must be sufficiently specific in explaining why Medicare
will likely deny the claim. Centers for Medicare &amp; Medicaid Servs., Dep't of
Health &amp; Human Servs., <i>Medicare Claims Processing Manual</i>, ch. 30, &sect;
40.3.6.1. The supplier's notice must also explain that denial is probable,
not merely possible. <i>Id.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b><i>FACTS AND PROCEDURAL HISTORY</i></b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Plaintiff International Rehabilitative Sciences, Inc., doing business
under the name RS Medical, supplies the BIO-1000, a piece of medical
equipment that delivers electrical impulses to the knee to treat
osteoarthritis of the knee.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  RS Medical charges more than $4,000 for a single-knee BIO-1000 and more
than $5,000 for a dual-knee BIO-1000. By comparison, similar devices called
"transcutaneous electric nerve stimulators," also known as TENS units, cost
less than $800. <i>See</i> Centers for Medicare &amp; Medicaid Services Durable Medical
Equipment Fee Schedule (Jan.2012), available at
&lt;http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/DMEPOSFeeSched/DMEPOS-Fee-Schedule-Items/CMS
1254095.html&gt;.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  RS Medical began filing Medicare coverage claims for the BIO-1000 in 2004.
At first, those claims were largely denied. Over the next few years, RS
Medical started to receive more coverage approvals from initial contractors,
qualified independent contractors, and ALJs. In fact, coverage of the device
was approved many times at these lower levels of the process. However, none
of those coverage decisions reached the Medicare Appeals Council until now.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This case arises from more than 1000 separate claims for Medicare coverage
of the BIO-1000 made by RS Medical on behalf of more than 400 individual
beneficiaries. Each claim was denied by a Medicare contractor upon the
initial determination and redetermination, then by a qualified independent
contractor, then by an ALJ, and finally, when the claims were consolidated,
by the Medicare Appeals Council in four separate decisions.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In each of the four decisions, the Medicare Appeals Council concluded that
RS Medical had not met its burden of establishing that the BIO-1000 was
"reasonable and necessary" for treatment. RS Medical had claimed the
BIO-1000 was reasonable and necessary for two purposes: (1) to alleviate
pain from osteoarthritis of the knee; and (2) to regenerate knee <span CLASS="page_no" data-cite="2012 bl 190064 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[**4]</span> cartilage.
With respect to the first purpose, the Medicare Appeals Council found that
RS Medical had not offered reliable evidence to establish that the BIO-1000
was more effective at alleviating pain than TENS units costing 80% less than
the BIO-1000. Although RS Medical submitted several studies purporting to
show the BIO-1000's effectiveness at alleviating pain, the Medicare Appeals
Council discounted those studies because, among other methodological flaws,
they had been authored or sponsored
<span CLASS="page_no" data-cite="688 f 3d 999" data-cite-type="PrimaryFederalReporter" data-cite-pageno="999" data-primary-citation="688 F.3d 994">[*999]</span> 
by the BIO-1000 manufacturer. And with respect to the second purpose, the
Medicare Appeals Council found that although some evidence showed that the
BIO-1000 could regenerate cartilage in rabbits and cows, no evidence showed
that it was effective at regenerating cartilage in humans. In sum, the
Medicare Appeals Council concluded that the medical literature did not show
that the BIO-1000 was generally accepted by the medical community. It denied
Medicare coverage for the BIO-1000.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Further, with respect to the limited liability provisions, the Medicare
Appeals Council declined to indemnify RS Medical for the coverage denials.
It found that RS Medical "knew or had reason to know that Medicare would not
cover the device" because "its efficacy had not been established in the
requisite peer-reviewed literature" and because "the record does not
indicate general acceptance of the device by the medical community."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, the Medicare Appeals Council declined to shift liability from RS
Medical to most of the individual Medicare beneficiaries, with some
exceptions. It found that most of the advance beneficiary notices provided
by RS Medical were generic and thus insufficient to shift liability to the
beneficiaries.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  After the Medicare Appeals Council denied its coverage claims, RS Medical
filed this action challenging the denials as arbitrary, capricious, and not
supported by substantial evidence. <i>See</i><a href="/document/XEGP3C003?jcsearch=5%20usc%20706&amp;summary=yes#jcite">5 U.S.C. &sect; 706</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Both parties moved for summary judgment. The district court granted RS
Medical's motion and denied the Secretary's motion. <i>Int'l Rehabilitative</i>
<i>Scis., Inc. v. Sebelius</i>, <a href="/document/X1F5OKM003?jcsearch=737%20f%20supp%202d%201281&amp;summary=yes#jcite">737 F.Supp.2d 1281</a>, <a href="/document/X1F5OKM003?jcsearch=737%20f%20supp%202d%201281&amp;summary=yes#jcite">1284</a> (W.D.Wash.2010). It first
concluded that the Medicare Appeals Council's decisions were not entitled to
deference because they were inconsistent with many ALJ decisions in
individual cases granting Medicare coverage for the BIO-1000 &mdash; even though
those grants were at lower levels of the adjudication process, not by the
Medicare Appeals Council. <i></i><a href="/document/X1F5OKM003?jcsearch=737%20F.%20Supp.%202d%201281&amp;summary=yes#jcite">Id. at 1288-90</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court, explicitly proceeding de novo and without any
deference to the agency, compared the strength of the evidence supporting
the Medicare Appeals Council's four coverage denials with the strength of
the evidence supporting a number of ALJ coverage grants not at issue in this
case. First, the district court concluded that the Medicare Appeals Council
coverage denials gave no weight to the fact that the FDA had cleared the
BIO-1000 as safe and effective. <i></i><a href="/document/X1F5OKM003?jcsearch=737%20F.%20Supp.%202d%201281&amp;summary=yes#jcite">Id. at 1291-92</a>. Second, in the district
court's view, the evidence as a whole showed the medical community's
widespread <span CLASS="page_no" data-cite="2012 bl 190064 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[**5]</span> acceptance of the BIO-1000 for alleviating pain. <i></i><a href="/document/X1F5OKM003?jcsearch=737%20F.%20Supp.%202d%201281&amp;summary=yes#jcite">Id. at 1292-93</a>.
The district court held that the ALJ coverage grants not at issue here were
"more based on substantial evidence than the [Medicare Appeals Council]
denials at issue here." <i></i><a href="/document/X1F5OKM003?jcsearch=737%20F.%20Supp.%202d%201281&amp;summary=yes#jcite">Id. at 1293</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Having reversed the Medicare Appeals Council's coverage denials, the
district court did not reach the limited liability issues of whether
Medicare should indemnify RS Medical on the ground that the coverage denials
were unforeseeable and whether RS Medical's advance beneficiary notices were
sufficiently specific to shift liability for the BIO-1000's cost to the
individual Medicare beneficiaries. <i></i><a href="/document/X1F5OKM003?jcsearch=737%20F.%20Supp.%202d%201281&amp;summary=yes#jcite">Id. at 1293</a>. The district court remanded
the claims to the Medicare Appeals Council to determine the appropriate
payment amounts. <i></i><a href="/document/X1F5OKM003?jcsearch=737%20F.%20Supp.%202d%201281&amp;summary=yes#jcite">Id. at 1294</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Secretary moved to amend the district court's judgment under Federal
Rule of Civil Procedure <a href="/document/X144L4I003?jcsearch=FRCIVPRO%2059&amp;summary=yes#jcite">59</a>(e). She argued that the district court's opinion
was wrong and that newly discovered evidence showed that the Medicare
Appeals Council's coverage
<span CLASS="page_no" data-cite="688 f 3d 1000" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1000" data-primary-citation="688 F.3d 994">[*1000]</span> 
denials were consistent with coverage decisions at other levels of agency
adjudication. In support of her motion, the Secretary submitted BIO-1000
coverage decisions from lower levels of agency adjudication over the past
three years consistently denying coverage for the BIO-1000 &mdash; including by
some of the same ALJs who had granted coverage for the BIO-1000 in its early
years.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court denied the Secretary's motion to amend the judgment. It
again found that the agency's coverage decisions were inconsistent, and thus
the Medicare Appeals Council's coverage denials were arbitrary.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The agency appeals.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  While this appeal was pending, the Fourth Circuit decided an almost
identical case, <i>Almy v. Sebelius</i>, <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">679 F.3d 297</a> (4th Cir.2012), involving the
exact same device, brought by the device's manufacturer. BioniCare, the
BIO-1000's manufacturer, brought a district court action challenging a
number of Medicare Appeals Council decisions denying coverage for the
BIO-1000 &mdash; including some of the same Medicare Appeals Council decisions at
issue here &mdash; as arbitrary, capricious, and not supported by substantial
evidence.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Almy</i>, the Fourth Circuit upheld the coverage denials. It held that
substantial evidence supported the coverage denials because, as the Medicare
Appeals Council explained, the studies submitted by the BIO-1000
manufacturer suffered from methodological flaws that weakened their
persuasiveness, objectivity, and relevance. <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">679 F.3d at 305-07</a>. The Fourth
Circuit further held that the Medicare Appeals Council coverage denials were
not impermissibly arbitrary, even though the agency had previously granted
some coverage claims for the BIO-1000 at lower levels in the agency
adjudication process, because the Medicare Appeals Council had consistently
denied coverage. <i></i><a href="/document/X1HK8FA003?jcsearch=679%20F.3d%20297&amp;summary=yes#jcite">Id. at 310-11</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b><i>JURISDICTION</i></b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court had jurisdiction under <a href="/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(b)(1)(A)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395ff</a>(b)(1)(A) and
<a href="/document/X197B84003?jcsearch=42%20U.S.C.%20%20405(g)&amp;summary=yes#jcite">42 U.S.C. &sect; 405</a>(g). We have jurisdiction under <a href="/document/XEIMU8003?jcsearch=28%20usc%201291&amp;summary=yes#jcite">28 U.S.C. &sect; 1291</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b><i>STANDARD OF REVIEW</i></b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We review a district court's grant of summary judgment de novo and denial
of a Rule 59(e) motion to amend <span CLASS="page_no" data-cite="2012 bl 190064 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[**6]</span> judgment for abuse of discretion. <i>Lopez v.</i>
<i>Smith</i>, <a href="/document/X3F79S?jcsearch=203%20f%203d%201122&amp;summary=yes#jcite">203 F.3d 1122</a>, <a href="/document/X3F79S?jcsearch=203%20f%203d%201122&amp;summary=yes#jcite">1131</a> (9th Cir.2000) (en banc); <i>Floyd v. Laws</i>,
<a href="/document/X30KCT?jcsearch=929%20f%202d%201390&amp;summary=yes#jcite">929 F.2d 1390</a>, <a href="/document/X30KCT?jcsearch=929%20f%202d%201390&amp;summary=yes#jcite">1400</a> (9th Cir.1991).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Secretary's denial of coverage will be affirmed unless it is
"arbitrary, capricious, an abuse of discretion, or otherwise not in
accordance with law." <a href="/document/XEGP3C003?jcsearch=5%20usc%20706&amp;summary=yes#jcite">5 U.S.C. &sect; 706</a>. The Secretary's factual findings are
conclusive if they are supported by "substantial evidence."
<a href="/document/X197B84003?jcsearch=42%20U.S.C.%20%20405(g)&amp;summary=yes#jcite">42 U.S.C. &sect; 405</a>(g); <i>see also</i><a href="/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(b)(1)(A)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395ff</a>(b)(1)(A). "Substantial
evidence" means "'more than a mere scintilla but less than a preponderance;
it is such relevant evidence as a reasonable mind might accept as adequate
to support a conclusion.'" <i>Sandgathe v. Chater</i>, <a href="/document/XTJULNQNB5G0?jcsearch=108%20f%203d%20978&amp;summary=yes#jcite">108 F.3d 978</a>, <a href="/document/XTJULNQNB5G0?jcsearch=108%20f%203d%20978&amp;summary=yes#jcite">980</a> (9th
Cir.1997) (quoting <i>Andrews v. Shalala</i>, <a href="/document/X3I9CO?jcsearch=53%20f%203d%201035&amp;summary=yes#jcite">53 F.3d 1035</a>, <a href="/document/X3I9CO?jcsearch=53%20f%203d%201035&amp;summary=yes#jcite">1039</a> (9th Cir.1995)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b><i>ANALYSIS</i></b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>I. THE AGENCY'S COVERAGE DENIALS FOR THE BIO-1000</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court reversed the Medicare Appeals Council's coverage
denials on two independent grounds. We disagree on both.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  First, the district court held that the thousands of coverage grants by
initial contractors, qualified independent contractors, and ALJs rendered
the Medicare Appeals Council's coverage denials here "arbitrary and
capricious" under <a href="/document/XEGP3C003?jcsearch=5%20U.S.C.%20%20706&amp;summary=yes#jcite">&sect; 706</a> of the
<span CLASS="page_no" data-cite="688 f 3d 1001" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1001" data-primary-citation="688 F.3d 994">[*1001]</span> 
Administrative Procedure Act. But not all agency inconsistency is
impermissibly arbitrary &mdash; only <i>"[u]nexplained</i> inconsistency."
<i>Marmolejo-Campos v. Holder</i>, <a href="/document/X1ALR88003?jcsearch=558%20f%203d%20903&amp;summary=yes#jcite">558 F.3d 903</a>, <a href="/document/X1ALR88003?jcsearch=558%20f%203d%20903&amp;summary=yes#jcite">914</a> (9th Cir.2009) (en banc)
(alteration in original) (emphasis added). "[Agency] inconsistency provides
a basis for rejecting an agency's interpretation only in 'rare instances,
such as when an agency <i>provides no explanation at all for a change in</i>
<i>policy</i>, or when its explanation is so un-clear or contradictory that we are
left in doubt as to the reason for the change in direction.'" <i><a href="/document/X1ALR88003?jcsearch=558%20F.3d%20903&amp;summary=yes#jcite">Id</a>.</i> (emphasis
added) (citation omitted). Here, the Medicare Appeals Council explained why
it disagreed with the lower agency adjudicatory decisions granting coverage:
the studies that those decisions relied on purporting to show the BIO-1000's
effectiveness at alleviating pain had been authored or sponsored by the
BIO-1000 manufacturer, and the studies purporting to show the BIO-1000's
effectiveness at regenerating cartilage had been conducted on animals, not
humans. Because they explained the reasons for their disagreement, the
Medicare Appeals Council's coverage denials were not impermissibly
arbitrary.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, the district court incorrectly measured agency inconsistency
across different levels of agency adjudication. No Medicare Appeals Council
decision has granted coverage for the BIO-1000; the only coverage grants
were by contractors, qualified independent contractors, and ALJs. As the
Fourth Circuit held in this exact situation, "'[e]ven if these [decisions
from lower levels of agency adjudication] were found to evince internal
inconsistency at a subordinate level, the [agency] itself would not be
acting inconsistently.'" <i>Almy v. Sebelius</i>, <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">679 F.3d 297</a>, <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">310</a> (4th Cir.2012)
(third alteration in original) (quoting <i>Cmty. Care Found, v. Thompson</i>,
<a href="/document/X6B5HJ?jcsearch=318%20f%203d%20219&amp;summary=yes#jcite">318 F.3d 219</a>, <a href="/document/X6B5HJ?jcsearch=318%20f%203d%20219&amp;summary=yes#jcite">227</a> (D.C.Cir.2003) (holding that Secretary's denial of
Medicare Part A payments was not arbitrary and capricious even though it was
inconsistent with prior lower-level agency adjudicatory decisions)). The
Fourth Circuit illustrated <span CLASS="page_no" data-cite="2012 bl 190064 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[**7]</span> the district court's error by analogy: "The
decisions of local contractors cannot deprive [the Secretary] of that
discretion [to determine when a device is reasonable and necessary], any
more than the diverse decisions of district courts or courts of appeals
throughout the country could bind the Supreme Court." <i></i><a href="/document/X1HK8FA003?jcsearch=679%20F.3d%20297&amp;summary=yes#jcite">Id. at 311</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  RS Medical argues that the agency has regulatory tools that could remedy
these inconsistencies &mdash; in particular, it can issue local or national
coverage determinations (i.e., up-front rules about whether a particular
item is covered). <i>See</i><a href="/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(f)(1)(B)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395ff</a>(f)(1)(B), <a href="/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(f)(2)(B)&amp;summary=yes#jcite">(2)(B).</a> But while the
agency <i>may</i> make coverage determinations via up-front rules, it is not
<i>required</i> to do so; rather, the agency has discretion in whether to make
coverage determinations by up-front rulemaking or by case-by-case
adjudication. <i>See Almy</i>, <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">679 F.3d at 303-04</a>; <i>see also Heckler v. Ringer</i>,
<a href="/document/X5CATS?jcsearch=466%20us%20602&amp;summary=yes#jcite">466 U.S. 602</a>, <a href="/document/X5CATS?jcsearch=466%20us%20602&amp;summary=yes#jcite">617</a>, <a href="/document/X5CATS?jcsearch=104%20supreme%20court%202013&amp;summary=yes#jcite">104 S.Ct. 2013</a>, <a href="/document/X5CATS?jcsearch=80%20l%20ed%202d%20622&amp;summary=yes#jcite">80 L.Ed.2d 622</a> (1984) ("The Secretary's
decision as to whether a particular medical service is 'reasonable and
necessary' and the means by which she implements her decision, whether by
promulgating a generally applicable rule or by allowing individual
adjudication, are clearly discretionary decisions."). As the Fourth Circuit
noted in <i>Almy</i>, "directly applicable Supreme Court precedent . . . makes
clear that the Secretary enjoys full discretion to choose to proceed by
adjudication rather than by rulemaking." <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">679 F.3d at 303</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We hold that the Medicare Appeals Council's coverage denials were not
arbitrary.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Second, the district court, having found that the Medicare Appeals Council
decisions denying coverage were arbitrary, then compared those decisions
side-by-side
<span CLASS="page_no" data-cite="688 f 3d 1002" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1002" data-primary-citation="688 F.3d 994">[*1002]</span> 
against the lower-level agency decisions granting coverage and concluded
that the coverage grants were "more based on substantial evidence than the
[Medicare Appeals Council] denials at issue here." <a href="/document/X1F5OKM003?jcsearch=737%20f%20supp%202d%201281&amp;summary=yes#jcite">737 F.Supp.2d at 1293</a>;
<i>see also </i><a href="/document/X1F5OKM003?jcsearch=737%20F.%20Supp.%202d%201281&amp;summary=yes#jcite">id. at 1291</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As a preliminary matter, the district court misapplied the "substantial
evidence" standard of review. That standard requires the district court to
determine whether the agency decision <i>on direct review</i> is supported by
substantial evidence. It does not give the district court license to compare
the agency decision on direct review with other agency decisions not on
review and determine which is supported by more substantial evidence. That
would be tantamount to de novo review, which is not the standard.
<i>See</i><a href="/document/X197B84003?jcsearch=42%20U.S.C.%20%20405(g)&amp;summary=yes#jcite">42 U.S.C. &sect; 405</a>(g); <i>Sandgathe v. Chater</i>, <a href="/document/XTJULNQNB5G0?jcsearch=108%20f%203d%20978&amp;summary=yes#jcite">108 F.3d 978</a>, <a href="/document/XTJULNQNB5G0?jcsearch=108%20f%203d%20978&amp;summary=yes#jcite">980</a> (9th
Cir.1997).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Medicare Appeals Council held that RS Medical had not met its burden
of showing that the BIO-1000 was "reasonable and necessary" because the
studies it submitted purporting to show the BIO-1000's effectiveness
suffered from methodological flaws. Among other flaws, the studies RS
Medical submitted allegedly showing the BIO-1000's effectiveness <i>at</i>
<i>alleviating pain</i> had been authored or sponsored by the BIO-1000
manufacturer, thus bringing their objectivity into question. And the studies
RS Medical submitted purporting to show the BIO-1000's effectiveness at
<i>regenerating cartilage</i> had been conducted on rabbits and cows, not humans,
thus lessening their relevance.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court held <span CLASS="page_no" data-cite="2012 bl 190064 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[**8]</span> that the Medicare Appeals Council's decisions
"gave no weight to the FDA's clearance of the BIO-1000 for the purpose of
treating symptoms of osteoarthritis." <a href="/document/X1F5OKM003?jcsearch=737%20f%20supp%202d%201281&amp;summary=yes#jcite">737 F.Supp.2d at 1291</a>. FDA clearance,
however, is <i>necessary</i>, but not <i>sufficient</i>, for Medicare coverage.
<a href="/document/1?citation=68%20federal%20register%2055634&amp;summary=yes#jcite">68 Fed.Reg. 55,634</a>, 55,636 (Sept. 26, 2003). FDA review and Medicare
coverage review have different purposes. <i>Id.</i> FDA review seeks to determine
whether a device is "safe and effective" such that it can be marketed to the
general public. By contrast, Medicare coverage review seeks to determine
whether the device is "reasonable and necessary" for treatment such that the
device is worth the government's money. <i>Medicare Benefit Policy Manual</i>, ch.
15, &sect; 110.1[C][2]. To be "reasonable and necessary" for treatment, a device
must be "safe and effective," but other considerations are also relevant &mdash;
like whether there are less costly but equally effective devices available.
<i>Id.</i> As the Fourth Circuit held in <i>Almy</i>, "[w]hile FDA approval may . . .
inform the Secretary's decision as to whether a device is 'reasonable and
necessary,' it cannot tie the Secretary's hands." <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">679 F.3d at 308</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Additionally, the <i>type</i> of FDA clearance is relevant to whether Medicare
will cover a device. Section 510(k) clearance &mdash; the type of clearance given
to the BIO-1000 &mdash; is a less rigorous type of FDA review. See
<a href="/document/XEI5PI003?jcsearch=21%20U.S.C.%20%20360c(f)(1)(A)&amp;summary=yes#jcite">21 U.S.C. &sect; 360c</a>(f)(1)(A). It requires the provider to show only that the
device is "substantially equivalent" to (that is, as safe and as effective
as) a device legally on the market before 1976, when the FDA began
regulating medical devices. <i>See Riegel v. Medtronic, Inc.</i>, <a href="/document/X18HPKU003?jcsearch=552%20us%20312&amp;summary=yes#jcite">552 U.S. 312</a>,
<a href="/document/X18HPKU003?jcsearch=552%20us%20312&amp;summary=yes#jcite">317</a>, <a href="/document/1?citation=128%20supreme%20court%20999&amp;summary=yes#jcite">128 S.Ct. 999</a>, <a href="/document/X18HPKU003?jcsearch=169%20l%20ed%202d%20892&amp;summary=yes#jcite">169 L.Ed.2d 892</a> (2008). In effect, Section 510(k)
clearance allows a new device to piggy-back off the approval of a
grandfathered device &mdash; here, a TENS unit. By contrast, Section 515 premarket
approval is a much more rigorous safety review in which the FDA examines all
studies and investigations of the device's safety and effectiveness. <i>Id.</i> at
317-18, <a href="/document/1?citation=128%20supreme%20court%20999&amp;summary=yes#jcite">128 S.Ct. 999</a>. Thus, the fact that the BIO-1000 received only the
less rigorous 510(k) FDA clearance further undercuts the district court's
holding that the Medicare
<span CLASS="page_no" data-cite="688 f 3d 1003" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1003" data-primary-citation="688 F.3d 994">[*1003]</span> 
Appeals Council gave it insufficient weight.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court also held that the Medicare Appeals Council's coverage
denials were not supported by substantial evidence because they overlooked
evidence showing "the medical community's widespread acceptance of the
BIO-1000 as a reasonable treatment for osteoarthritis."
<a href="/document/X1F5OKM003?jcsearch=737%20f%20supp%202d%201281&amp;summary=yes#jcite">737 F.Supp.2d at 1292-93</a>. In particular, the district court concluded that
the Medicare Appeals Council improperly discounted the studies published in
peer-reviewed journals purporting to show the BIO-1000's effectiveness at
alleviating knee pain on the ground that those studies had been authored or
sponsored by the BIO-1000 manufacturer and failed to consider that many
other insurers cover the BIO-1000. <i></i><a href="/document/X1F5OKM003?jcsearch=737%20F.%20Supp.%202d%201281&amp;summary=yes#jcite">Id. at 1293</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  With respect to the studies published in peer-reviewed journals,
Medicare's own guidance manual explains &mdash; as the Medicare Appeals Council
held here &mdash; that "limited case studies distributed by sponsors with
financial interest in the outcome[] are not sufficient evidence of general
acceptance by the medical community."<a HREF="#fn100" name="fnref_fn100">[fn1]</a> Centers for Medicare &amp; Medicaid
<span CLASS="page_no" data-cite="2012 bl 190064 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[**9]</span> Servs., Dep't of Health and Human Servs., <i>Medicare Program Integrity Manual</i>
&sect; 13.7.1. Additionally, the Medicare Appeals Council decisions adopted or
approved the reasoning of the underlying ALJ decisions denying coverage,
each of which detailed additional methodological flaws in the studies &mdash;
i.e., the studies were not double-blind or random. Thus, the Medicare
Appeals Council provided adequate reasons for discounting the studies
authored or sponsored by the BIO-1000 manufacturer. As the Fourth Circuit
explained in <i>Almy</i>: "It is not our office to tender an independent judgment
on the value and validity of the various scientific studies submitted. We
ask only whether the Secretary's assessment was a reasonable one, and we are
satisfied that it was." <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">679 F.3d at 305-06</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  With respect to other insurers' coverage of the BIO-1000, the district
court erred in holding that that fact alone established the medical
community's general acceptance of the BIO-1000. The Medicare guidance manual
explains that "[a]cceptance by individual health care providers, or even a
limited group of health care providers, normally does not indicate general
acceptance by the medical community." <i>Medicare Program Integrity Manual</i> &sect;
13.7.1. Rather, whether a device is generally accepted by the medical
community depends on, in decreasing order of importance, "[s]cientific data
or research studies published in peer-reviewed medical journals,"
"[c]onsensus of expert medical opinion (i.e., recognized authorities in the
field)," and "[m]edical opinion derived from consultations with medical
associations or other health care experts." <i>Id.</i> Consistent with those
standards, the Medicare Appeals Council reasonably concluded that neither
research studies nor expert medical consensus established the medical
community's general acceptance of the BIO-1000.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  RS Medical argues that the fact that the agency had assigned a Healthcare
Common Procedure Coding System billing code and fee schedule for the
BIO-1000 showed that the agency had determined that the
<span CLASS="page_no" data-cite="688 f 3d 1004" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1004" data-primary-citation="688 F.3d 994">[*1004]</span> 
device was covered by Medicare. But the fact that an item receives a billing
code or fee schedule does not mean it is covered by Medicare, as the billing
code and fee schedule manuals caution. Rather, the purpose of those codes
and schedules is to promote uniform reporting and statistical data
collection. They are used not only by Medicare, but also by private insurers
and state Medicaid programs. As the Fourth Circuit held in <i>Almy</i>, the fact
that the BIO-1000 had received a billing code and fee schedule does not
undermine the substantial evidence supporting the Medicare Appeals Council's
coverage denials. <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">679 F.3d at 307</a> n. 3.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In sum, we hold that the district court erred in finding that there was
not substantial evidence supporting the Medicare Appeals Council's coverage
denials for the BIO-1000 on the ground that the medical literature did not
establish the medical community's general acceptance of the device. We agree
with the Fourth Circuit:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      Using the appropriate standard of review and burden of proof, the
    Secretary's determination <span CLASS="page_no" data-cite="2012 bl 190064 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[**10]</span> that [the BIO-1000's supplier] did not
    establish that the BIO-1000 was "safe and effective" and "not
    experimental or investigational" was in fact supported by
    substantial evidence. . . . The [Medicare Appeals Council] reviewed
    the studies submitted by [the BIO-1000's supplier] in support of the
    BIO-1000 and identified numerous deficiencies that deprived them of
    persuasive value.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Almy</i>, <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">679 F.3d at 305-06</a>. Thus, we reverse the district court's grant of
summary judgment in favor of RS Medical.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>II. INDEMNIFICATION AND SHIFTING LIABILITY TO BENEFICIARIES</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Because the district court reversed the Medicare Appeals Council's
coverage denials, it did not reach the issues of whether substantial
evidence supported the Medicare Appeals Council's decision not to indemnify
RS Medical for the coverage denials under the "limited liability" provision
on the ground that the denials were foreseeable and whether substantial
evidence supported the Medicare Appeals Council's conclusions about which of
the panoply of advance beneficiary notices in the record were sufficiently
specific to shift liability to individual beneficiaries and which were too
generic. <a href="/document/X1F5OKM003?jcsearch=737%20f%20supp%202d%201281&amp;summary=yes#jcite">737 F.Supp.2d at 1293-94</a>; <a href="/document/XEJAMC003?jcsearch=42%20usc%201395pp&amp;summary=yes#jcite">42 U.S.C. &sect; 1395pp</a>. The district court
should determine these issues in the first instance on remand.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>REVERSED AND REMANDED.</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> RS Medical argues that this regulation does not apply because the
studies it submitted were merely "authored" &mdash; not "distributed" &mdash; by the
BIO-1000's sponsors. But as the Fourth Circuit explained in <i>Almy</i>: "Given the
substantial deference that we owe the Secretary's reasonable interpretations
of her own regulations . . . we cannot conclude that her actions were
unreasonable. It is a maxim of evidence that a party's interest in a
potential outcome can affect his objectivity, and the [guidance manual]
regulation is clearly directed at ensuring that coverage decisions rest on
an objective and disinterested foundation." <a href="/document/X1HK8FA003?jcsearch=679%20f%203d%20297&amp;summary=yes#jcite">679 F.3d at 306</a> (citation
omitted).
</p></div>

<!--BBLS DD 1719619289091-->

</div>
</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='bootstrap sideBarContent sidebar' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>

BCite Analysis

</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>

<a href="/bcite/X1I1GKO003/history">Direct History (5)</a>

</div>
<div class='bciteRenderer clearfix'>
<div class='bold sidebarItemLabel'>

No Negative Direct History

</div>
</div>

</div>

<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>

<a href="/bcite/X1I1GKO003/analysis">Case Analysis (8)</a>

</div>
<div class='bciteRenderer bciteResult clearfix'>
<img class='icon printOnly' src='/assets/citation_icons/positive.png'>
<a href="/bcite/X1I1GKO003/analysis?analysis=BCITE_POSITIVE_GROUP" class="icon citation positive" title="Positive"></a>
<a href="/bcite/X1I1GKO003/analysis?analysis=BCITE_POSITIVE_GROUP" class="citationAnalysisLabel">Positive</a>

<span class='citationNumberLabel'>
8
</span>
</div>

</div>

<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>



</div>
<div class='bciteRenderer clearfix'>
<div class='sidebarItemLabel small'>

<a href="/help/BLAWHelpSystem.htm#BCite_Indicators.htm" breadcrumb="" context="" hide_crumbs="false" id="X1I1GKO003" is_home="false" nav_page_path="" resource="" root_path="/" rule="RULE_DOCUMENT" search_id="" target="_blank" use_crumbs="true">Description of BCite Indicators</a>

</div>
</div>

</div>

</div>

<div class='sidebarSection'>
<div class='sidebarTitle'>

General Information

</div>
<div class='clearfix sidebarSectionDivider sidebarSubsection'>
<div class='facetItemHeading'>

Result(s)

</div>
<div class='clearfix'>
<div class='facetItemLabel'>

Case Remanded, Judgment Reversed

</div>
</div>

</div>

<div class='clearfix sidebarSectionDivider sidebarSubsection'>
<div class='facetItemHeading'>

Bloomberg Law Citation

</div>
<div class='clearfix'>
<div class='facetItemLabel'>

2012 BL 190064

</div>
</div>

</div>

<div class='clearfix sidebarSectionDivider sidebarSubsection'>
<div class='facetItemHeading'>

Industries

</div>
<div class='clearfix'>
<div class='facetItemLabel'>

Medical Devices & Imaging

</div>
</div>

<div class='clearfix'>
<div class='facetItemLabel'>

Health Insurance

</div>
</div>

</div>

<div class='clearfix sidebarSectionDivider sidebarSubsection'>
<div class='facetItemHeading'>

Related Docket(s)

</div>
<div class='clearfix'>
<div class='facetItemLabel'>

<a href="/document/2048032486360834">11-35254 (9th Cir.)</a>

</div>
</div>

</div>

<div class='clearfix sidebarSectionDivider sidebarSubsection'>
<div class='facetItemHeading'>

 Topic(s)

</div>
<div class='clearfix'>
<div class='facetItemLabel'>

Administrative Law

</div>
</div>

<div class='clearfix'>
<div class='facetItemLabel'>

Insurance Law

</div>
</div>

</div>

<div class='clearfix sidebarSectionDivider sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>

Judge(s)

</div>
<div class='clearfix' id='judges_section_loader'>
<div class='facetItemLabel'>



</div>
</div>

</div>

</div>

</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="LpSXuBb3zp4DxNnwkq54A2leqj4MsxHanJdvSqU4rnE=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var PRODUCT_ID = "BLAW";
var PATH_FOR_PRODUCT = "";
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/";
var RESULTS_ROOT_PATH = "/search/results/";
var DOWNLOAD_CENTER_PATH = "/download/download_center/file/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "";
var BC_ID = "";
CRUMB_ID = "";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_73ac3ac77309c1c289fb458709561dea';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=Int%27l+Rehabilitative+Sciences%2C+Inc.+v.+Sebelius%2C+688+F.3d+994+%289th+Cir.+2012%29%2C+Court+Opinion+-+Bloomberg+Law+%0A&activityInstanceId=ENTITY35468d&previousPageId=Int%27l+Rehabilitative+Sciences%2C+Inc.+v.+Sebelius%2C+688+F.3d+994+%289th+Cir.+2012%29%2C+Court+Opinion+-+Bloomberg+Law+%0A&previousActivityInstanceId=ENTITYbfae8c&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-08-20T03:33:34-04:00&bprod=BLAW';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_73ac3ac77309c1c289fb458709561dea&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
var NOTIFICATIONS_APP;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
if( typeof Juggernaut !== 'undefined' ){
JUG = new Juggernaut({
host:'push.bloomberglaw.com',
secure: true,
port: 443
});
JUG.subscribe("webserver2:public_broadcast", function(data){});
JUG.subscribe("63166_73ac3ac77309c1c289fb458709561dea", function(data){});
}
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
USER_IS_FIRM_USER="false";
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=NONE&docId=X1I1GKO003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=Int%27l+Rehabilitative+Sciences%2C+Inc.+v.+Sebelius%2C+688+F.3d+994+%289th+Cir.+2012%29%2C+Court+Opinion+-+Bloomberg+Law+%0A&activityInstanceId=ENTITYbfae8c&previousPageId=United+States+v.+Jones%2C+689+F.3d+12+%281st+Cir.+2012%29%2C+Court+Opinion+-+Bloomberg+Law+%0A&previousActivityInstanceId=ENTITYf4efca&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-08-20T03:33:33-04:00&bprod=BLAW';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1I1GKO003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1I1GKO003";
$('#page_loader').show().spin();
JUDGE_IDS=["3028728"];
JUDGE_NAMES=null;
</script>

<script src="/assets/activity_tracking/ni-6f84e5002a61c8d6da2bbf4a42b86099.js" type="text/javascript"></script>
<script src="/assets/activity_tracking/tracking-cc45253e40f1496b941fa3ce57a1464e.js" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="/terms_of_service" class="menuLink" target="BLAWTOS">Terms of Service</a>
 | 
<a href="/privacy_policy" class="menuLink" target="BLAWPRIVACY">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
<div class='version'>

243886
Gem
0.196.3
244395
 - 3.2.18
</div>
</div>
</div>
</div>

</div>
<div class='bbPopupContainer' id='bb_popup_container'>
<div class='popupTitle'>
<div class='popupClose close bb_popup_close'></div>
<h2 class='bb_popup_title'></h2>
</div>
<div class='popupContent bb_popup_content'></div>
</div>
<div class='maskOverlay' id='bb_popup_mask'></div>

</div>

</body>
</html>
